Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, UBA-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155, C1121ABG CABA, Argentina.
Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS), Facultad de Medicina, UBA-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Paraguay 2155, C1121ABG CABA, Argentina.
Curr Opin Immunol. 2023 Dec;85:102390. doi: 10.1016/j.coi.2023.102390. Epub 2023 Oct 6.
The SARS-CoV-2 pandemic caused millions of deaths around the world. This dramatic balance requires governments, international organizations, vaccine manufacturers, and the scientific community itself to take stock of what has been done and what could have been done better. In this sense, the tremendous inequity in access to vaccines, the main tool to deal with the pandemic, deserves deep reflection and a set of actions to be carried out by low- and middle-income countries. Among them, the construction of a joint effort to produce their own vaccines and the reconsideration of the bases that govern the intellectual property rights of vaccines and medicines, which harmed equitable access to health, with the consequent loss of many lives that could have been saved.
SARS-CoV-2 大流行导致了全球数百万人死亡。这种戏剧性的不平衡局面需要各国政府、国际组织、疫苗制造商和科学界自身对已经做了什么以及可以做得更好的方面进行评估。从这个意义上说，获得疫苗的巨大不平等，作为应对大流行的主要工具，值得深入反思，并需要中低收入国家采取一系列行动。其中包括，构建共同努力生产自己的疫苗的机制，以及重新考虑管理疫苗和药品知识产权的基础，这些基础损害了公平获得健康的机会，导致许多本可以挽救的生命的丧失。
